Vialwirebiotech, curated
July 2, 2026, 8:50 AM
June 28, 2026
- 12:00 AM · BioWorld12:00 AMFDA says yes to Viridian’s Lumvoa in TED — BioWorld
June 26, 2026
- 12:00 PM · BioWorld12:00 PMHigh-profile Nature retraction tests confidence in China-led studies — BioWorld
- 12:00 PM · BioWorld12:00 PMEMA to pull Amgen’s Tavneos over ‘incorrect and misleading’ data — BioWorld
- 11:49 AM · BioPharma Dive11:49 AMAt BIO, tension over China biotech deal regulation looms — BioPharma Dive
- 9:46 AM · BioPharma Dive9:46 AMAlkermes’ incoming CEO has a plan to outplay Lilly and Takeda — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMElixirgen and Nippon Shinyaku sign EXG-7001 option agreement — BioWorld
- 9:00 AM · BioWorld9:00 AMOblenio’s $62M series B for trispecific antibody in autoimmune diseases — BioWorld